Proteasome dysfunction in aged human alpha-synuclein transgenic mice

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder.
• A potential link between proteasome dysfunction and PD pathogenesis has been hypothesized.
• The ubiquitin-proteasome system (UPS) is crucial for protein degradation.

Purpose of the Study:

• To investigate the ubiquitin-proteasome system's function in a mouse model of Parkinson's disease.
• To compare proteasome activity and subunit levels in mice expressing wild-type and mutated alpha-synuclein.
• To correlate proteasome abnormalities with neurodegeneration in the substantia nigra.

Main Methods:

• Characterization of the ubiquitin-proteasome system in brain regions of transgenic and nontransgenic mice.
• Assessment of 20S proteasome activity.
• Quantification of 19S proteasome subunits (Rpt1, Rpn2) and high molecular weight ubiquitin conjugates.

Main Results:

• Mice expressing mutated alpha-synuclein (line hm2 alpha-SYN-39) exhibited significant proteasome impairments, including reduced proteolytic activity and lower levels of Rpt1 and Rpn2.
• These mice also showed increased levels of soluble high molecular weight ubiquitin cross-reacting proteins.
• Abnormalities in proteasome function were proportional to dopaminergic neuronal loss and consistent with findings in Parkinson's disease patients.

Conclusions:

• Deficits in proteasome function, specifically involving the 20S and 19S proteasome subunits, are present in a mouse model of Parkinson's disease with alpha-synuclein mutations.
• These findings support the hypothesis that proteasome dysfunction contributes to Parkinson's disease pathogenesis.
• The study highlights the correlation between proteasome impairment, alpha-synuclein pathology, and neurodegeneration in PD.